Your browser is no longer supported. Please, upgrade your browser.
Settings
NVTA Invitae Corporation daily Stock Chart
NVTA [NYSE]
Invitae Corporation
Index- P/E- EPS (ttm)-2.87 Insider Own1.70% Shs Outstand42.36M Perf Week-1.26%
Market Cap396.91M Forward P/E- EPS next Y-1.63 Insider Trans-1.03% Shs Float37.23M Perf Month-2.80%
Income-101.60M PEG- EPS next Q-0.62 Inst Own74.40% Short Float7.41% Perf Quarter-14.90%
Sales31.40M P/S12.64 EPS this Y5.00% Inst Trans-0.05% Short Ratio9.75 Perf Half Y6.12%
Book/sh1.94 P/B4.83 EPS next Y31.80% ROA-80.30% Target Price15.00 Perf Year14.55%
Cash/sh2.28 P/C4.10 EPS next 5Y8.00% ROE-117.80% 52W Range5.76 - 11.88 Perf YTD18.01%
Dividend- P/FCF- EPS past 5Y- ROI-88.80% 52W High-21.13% Beta-
Dividend %- Quick Ratio5.40 Sales past 5Y- Gross Margin0.70% 52W Low62.67% ATR0.31
Employees364 Current Ratio5.40 Sales Q/Q157.50% Oper. Margin- RSI (14)50.27 Volatility2.57% 3.35%
OptionableYes Debt/Eq0.51 EPS Q/Q20.50% Profit Margin- Rel Volume0.45 Prev Close9.35
ShortableYes LT Debt/Eq0.49 EarningsAug 07 AMC Payout- Avg Volume283.06K Price9.37
Recom2.00 SMA20-1.17% SMA501.05% SMA2003.78% Volume127,418 Change0.21%
Apr-03-17Reiterated The Benchmark Company Buy $11 → $16
Feb-14-17Upgrade The Benchmark Company Hold → Buy $8.50 → $11
Nov-10-16Resumed Leerink Partners Outperform
Jun-30-16Initiated The Benchmark Company Hold $8.50
Jan-28-16Downgrade Leerink Partners Outperform → Mkt Perform
Aug-14-15Initiated William Blair Mkt Perform
May-14-15Upgrade Leerink Partners Mkt Perform → Outperform
Jul-24-17 05:41PM  ETFs with exposure to Invitae Corp. : July 24, 2017 Capital Cube
07:30AM  Invitae to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 7, 2017 PR Newswire
Jul-14-17 03:57PM  ETFs with exposure to Invitae Corp. : July 14, 2017 Capital Cube
Jul-12-17 08:31AM  Invitae Corp. breached its 50 day moving average in a Bullish Manner : NVTA-US : July 12, 2017 Capital Cube
Jun-29-17 03:13PM  ETFs with exposure to Invitae Corp. : June 29, 2017 Capital Cube
Jun-28-17 09:00AM  Invitae Corp. breached its 50 day moving average in a Bearish Manner : NVTA-US : June 28, 2017 Capital Cube
Jun-14-17 08:15AM  Featured Company News - Invitae Acquires Ommdom; Gets CancerGene Connect Under its Portfolio Accesswire
Jun-12-17 07:30AM  Invitae Acquires CancerGene Connect, Award-Winning Risk Assessment and Family History Analysis Platform PR Newswire
Jun-05-17 02:35PM  ETFs with exposure to Invitae Corp. : June 5, 2017 Capital Cube
08:17AM  ASCO Data Shows Prostate Cancer Patients with Genetic Risk Factors Missed Under Current Testing Guidelines PR Newswire
Jun-02-17 10:18AM  Invitae Corp. :NVTA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
Jun-01-17 09:08AM  Invitae to present at the Goldman Sachs 38th Annual Global Healthcare Conference PR Newswire
May-26-17 04:56PM  How a cancer test maker started by former Twitter, Google execs hopes to change the world American City Business Journals
May-25-17 07:30AM  Invitae Broadens Management Team to Scale Expanding Business and Meet Rising Demand PR Newswire
May-12-17 07:30AM  Invitae to Present at the UBS Global Healthcare Conference PR Newswire
May-10-17 08:51AM  Invitae Corp. breached its 50 day moving average in a Bearish Manner : NVTA-US : May 10, 2017 Capital Cube
May-08-17 04:17PM  Invitae reports 1Q loss Associated Press
04:01PM  Invitae Exceeds 26,000 Samples Accessioned, Reports Revenue of $10.3 Million and Net Loss of $0.64 Per Share in First Quarter 2017 PR Newswire
Apr-28-17 04:08PM  ETFs with exposure to Invitae Corp. : April 28, 2017 Capital Cube
07:30AM  New research suggests current genetic testing guidelines may miss breast cancer patients who could benefit from testing PR Newswire
Apr-27-17 07:30AM  Invitae to Present at the Bank of America Merrill Lynch 2017 Health Care Conference PR Newswire
Apr-24-17 03:40PM  Invitae Corp. Value Analysis (NYSE:NVTA) : April 24, 2017 Capital Cube
07:30AM  Invitae to Announce First Quarter 2017 Financial Results and Host Conference Call on May 8, 2017 PR Newswire
Apr-21-17 08:45AM  Invitae Corp. breached its 50 day moving average in a Bullish Manner : NVTA-US : April 21, 2017 Capital Cube
Apr-20-17 07:30AM  Invitae announces expansion of its genetic test menu with addition of new tests and expanded panels for inherited metabolic and immune system disorders, including panels to confirm diagnoses suggested by newborn screening PR Newswire
Apr-06-17 10:41AM  A DNA-testing company is offering patients a chance to help find a cure for their conditions Business Insider
09:00AM  Invitae expands its Genome Network with the launch of the Invitae Patient Insights Network (PIN), enabling participants to share health information and contribute to research PR Newswire
Apr-03-17 07:30AM  Invitae announces new partnership with Alnylam Pharmaceuticals to provide TTR gene testing for patients suspected of having hereditary ATTR amyloidosis PR Newswire
Mar-30-17 03:05PM  3 Top Small-Cap Stocks to Buy Heading into April Motley Fool
07:30AM  Invitae announces introduction of exome testing PR Newswire
Mar-29-17 01:48PM  Shark Bites: Traders Could Trip on This Market Bounce TheStreet.com +5.51%
Mar-23-17 01:04PM  INVITAE CORP Financials
07:30AM  Invitae Expands Test Menu for Proactive Genetic Testing in Healthy Adults PR Newswire
Mar-22-17 07:30AM  Invitae announces expansion of its genetic testing offering to include unique test for Spinal Muscular Atrophy (SMA) during the 2017 ACMG Annual Clinical Genetics Meeting PR Newswire
Mar-19-17 11:45AM  3 Companies Whose Sales Could Double in 2017 Motley Fool
Mar-16-17 04:21PM  INVITAE CORP Files SEC form 10-K, Annual Report
Mar-14-17 07:30AM  Invitae to present seventeen posters and presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting PR Newswire
Mar-07-17 01:23PM  The Best Bet in the Growing Genetic Testing Market: Genetic Health vs. Invitae Motley Fool
Feb-21-17 11:07AM  Invitae to present at the Cowen and Company 37th Annual Health Care Conference PR Newswire +7.23%
Feb-17-17 07:30AM  New research suggests broader genetic testing of prostate cancer patients may be warranted to identify risk of an inherited mutation that might inform treatment PR Newswire
Feb-16-17 01:07PM  Invitae Corp. :NVTA-US: Earnings Analysis: 2016 By the Numbers : February 16, 2017 -5.13%
Feb-15-17 12:01PM  Invitae Corp. :NVTA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017
Feb-14-17 08:41AM  Invitae upgraded by The Benchmark Company +7.21%
Feb-13-17 04:42PM  INVITAE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:32PM  Invitae reports 4Q loss
04:01PM  Invitae reports revenue of $9.2 million in fourth quarter 2016 and projects strong volume and revenue growth in 2017 PR Newswire
01:00PM  5 Earnings Short-Squeeze Plays
07:07AM  Q4 2016 Invitae Corp Earnings Release - Time Not Supplied
Feb-09-17 05:02PM  INVITAE CORP Files SEC form 8-K, Change in Directors or Principal Officers
Jan-31-17 09:14AM  Growth Investing 2017: 3 Stocks to Put on Your Radar at Motley Fool
Jan-30-17 07:30AM  Invitae to announce fourth quarter and year-end 2016 financial results and 2017 guidance and will host conference call on February 13, 2017 PR Newswire
Jan-12-17 09:02AM  INVITAE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Jan-09-17 04:02PM  INVITAE CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and Ex +5.04%
07:30AM  Invitae announces new leadership structure to drive global growth PR Newswire
Jan-06-17 08:14AM  INVITAE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition
07:05AM  Invitae meets annual volume guidance, projects doubling of volume in 2017, accelerates Genome Network by acquiring scalable patient-centered data company PR Newswire
07:00AM  Invitae acquires patient-centered data company AltaVoice, creating new offerings to advance research and access to care for patients with inherited and rare diseases PR Newswire
Jan-05-17 08:25AM  Invitae (NVTA) Catches Eye: Stock Adds 5.9% in Session -6.36%
Dec-28-16 07:27AM  Invitae to present at the 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-23-16 01:00PM  ETFs with exposure to Invitae Corp. : December 23, 2016
Dec-21-16 07:27AM  Invitae announces major expansion of its pediatric, neurological, and rare disease genetic test offerings PR Newswire
Dec-20-16 07:20AM  The 1 Stock I'd Buy Right Now at Motley Fool
Dec-14-16 07:30AM  Invitae Sees Increase in Utilization of Its Inherited Prostate Cancer Genetic Tests Business Wire
Dec-12-16 09:00AM  Is InVitae Corp (NVTA) A Good Stock To Buy? at Insider Monkey
Dec-08-16 12:51PM  ETFs with exposure to Invitae Corp. : December 8, 2016
07:30AM  Invitae and TME Research Announce Landmark New Study to Evaluate Universal Genetic Testing of Breast Cancer Patients Business Wire
Dec-07-16 07:30AM  Invitae Adds Two Genes, Offers Faster Turnaround Time for Its Breast Cancer STAT Panel Business Wire
Dec-01-16 06:11AM  [$$] Three Biotechs With Bullish Insider Buying at Barrons.com
Nov-22-16 10:15PM  Invitae Corp (NVTA) Chairman and CEO Randal W Scott Bought $399,996 of Shares
Nov-17-16 04:46PM  INVITAE CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits -13.77%
07:35AM  Invitae to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum Business Wire
07:30AM  Invitae Announces Pricing of Public Offering of Common Stock Business Wire
Nov-15-16 05:22PM  INVITAE CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:13PM  Invitae Announces Proposed Public Offering of Common Stock Business Wire
Nov-10-16 12:48PM  ETFs with exposure to Invitae Corp. : November 10, 2016 +8.89%
Nov-09-16 11:31AM  Invitae Corp. :NVTA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016 +8.07%
Nov-07-16 04:49PM  Invitae reports 3Q loss +8.99%
04:44PM  INVITAE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:00PM  Invitae Announces Third Quarter 2016 Financial Results, Secures Contracts With Top Five Largest Payers, and Grows Volume More Than 200% Year-Over-Year Business Wire
07:07AM  Q3 2016 Invitae Corp Earnings Release - Time Not Supplied
Nov-04-16 10:51AM  Time to Get Greedy With This Under-the-Radar Stock at Motley Fool +8.66%
Oct-27-16 08:01AM  INVITAE CORP Files SEC form 8-K, Other Events
Oct-24-16 07:00AM  Invitae to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 7, 2016 Business Wire
Oct-20-16 12:10PM  The 'app store for genetics' just landed another major partner
Oct-19-16 08:00AM  Invitae Announces Multiple Scientific Presentations and Posters to Be Presented at the American Society of Human Genetics 2016 Annual Meeting Business Wire
Oct-18-16 08:00AM  Invitae Announces Collaboration With Helix to Build Applications for Health and Wellness Business Wire
Oct-13-16 06:14AM  INVITAE CORP Files SEC form 8-K, Other Events -6.04%
Oct-12-16 09:56AM  ETFs with exposure to Invitae Corp. : October 12, 2016
Oct-04-16 06:06AM  INVITAE CORP Files SEC form 8-K, Other Events
Oct-03-16 07:00AM  Invitae Announces Final Medicare Pricing Set at $925 for Hereditary Breast Cancer-Related Disorders Under New Billing Process Business Wire
Sep-30-16 11:00AM  Genetic Counselors Recognized by Patients, Peers for Excellence in Patient Care Business Wire
Sep-29-16 04:38PM  3 Signs Invitae's Best Days Are Ahead at Motley Fool
Sep-28-16 08:30AM  Invitae Presenting Research on Genetic Test Panels, Increasing Access to Genetic Counseling at the National Society of Genetic Counselors 35th Annual Education Conference Business Wire
Sep-27-16 10:12AM  ETFs with exposure to Invitae Corp. : September 27, 2016
Sep-17-16 02:11PM  Myriad Genetics Shouldn't Overlook This Tiny Competitor at Motley Fool
Sep-13-16 06:11AM  INVITAE CORP Files SEC form 8-K, Regulation FD Disclosure
Sep-07-16 10:59AM  ETFs with exposure to Invitae Corp. : September 7, 2016
Aug-25-16 10:24AM  ETFs with exposure to Invitae Corp. : August 25, 2016
Aug-15-16 07:00AM  Invitae Announces Major Expansion of Its Neurology and Cardiology Test Offerings Business Wire +6.04%
Aug-11-16 12:02PM  Invitae Corp. :NVTA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Invitae Corporation, a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare in the United States, Canada, Israel, and internationally. The company processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. It provides a diagnostic service comprising hundreds of genes for various genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. The company also offers solutions that enable sharing of genetic information consisting of Invitae Family History Tool, an online portal and mobile application that communicates sensitive patient data. In addition, it provides gene sequencing and deletion/duplication analysis; and free re-requisition of additional data within the same indication when ordered, as well as invests in informatics solutions and infrastructure that enable sharing of genetic information to enhance healthcare and clinical outcomes. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brida ThomasGeneral CounselFeb 16Sale9.697667,42024,720Feb 17 05:01 PM
Nussbaum Robert LChief Medical OfficerFeb 15Sale9.531,68616,06861,137Feb 15 08:22 PM
Stueland KatherineChief Commercial OfficerFeb 15Sale9.509118,65559,182Feb 15 08:23 PM
Brida ThomasGeneral CounselFeb 15Sale9.547947,57325,486Feb 15 08:20 PM
Dumond PattyVP Fin. & Principal Acct. Off.Feb 15Sale9.551,26412,06854,665Feb 15 08:21 PM
BENDEKGEY E LEEChief Financial OfficerFeb 15Sale9.592,09820,12058,784Feb 15 08:19 PM
Scott Randal WChairman and CEONov 22Buy6.0066,666399,9963,506,225Nov 22 06:07 PM
Crouse GeoffreyDirectorNov 18Buy6.2515,00093,75034,259Nov 21 07:14 PM
AGUIAR ERICDirectorNov 18Buy6.2810,00062,83410,000Nov 21 06:29 PM
BAKER BROS. ADVISORS LP10% OwnerNov 17Buy6.00733,3334,399,9986,480,668Nov 18 04:36 PM